Business Description
Mahamaya Lifesciences Ltd
ISIN : INE0U9D01019
Compare
Compare
Traded in other countries / regions
544611.India IPO Date
2025-11-18Description
Mahamaya Lifesciences Ltd specializes in the manufacturing of pesticide formulations and supplies bulk formulations catering to both Indian agrochemical companies as well as multinational corporations (MNCs). The company's offerings include Insecticides, Herbicides, and Fungicides. Geographically, it serves multiple Indian states including Punjab, Haryana, Rajasthan, and Uttar Pradesh, and internationally serves countries like the Dominican Republic, Turkey, Egypt, and the UAE. The company generates revenue from the sale of its pesticide formulations.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.43 | |||||
Equity-to-Asset | 0.39 | |||||
Debt-to-Equity | 0.74 | |||||
Debt-to-EBITDA | 5.07 | |||||
Interest Coverage | 3.79 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.96 | |||||
Beneish M-Score | -1.06 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 41.5 | |||||
3-Year EBITDA Growth Rate | 65.5 | |||||
3-Year EPS without NRI Growth Rate | 73.5 | |||||
3-Year FCF Growth Rate | -208.8 | |||||
3-Year Book Growth Rate | 84.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 45.78 | |||||
9-Day RSI | 45.85 | |||||
14-Day RSI | 46.38 | |||||
3-1 Month Momentum % | -4.42 | |||||
6-1 Month Momentum % | 2.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.45 | |||||
Quick Ratio | 0.68 | |||||
Cash Ratio | 0.22 | |||||
Days Inventory | 325.06 | |||||
Days Sales Outstanding | 131.22 | |||||
Days Payable | 161.02 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 18.31 | |||||
Operating Margin % | 9.79 | |||||
Net Margin % | 4.92 | |||||
EBITDA Margin % | 10.8 | |||||
FCF Margin % | -4.91 | |||||
OCF Margin % | -0.26 | |||||
ROE % | 9.52 | |||||
ROA % | 3.27 | |||||
ROIC % | 6.72 | |||||
3-Year ROIIC % | 9.67 | |||||
ROC (Joel Greenblatt) % | 13.96 | |||||
ROCE % | 18.22 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 45.16 | |||||
PE Ratio without NRI | 45.16 | |||||
PS Ratio | 2.21 | |||||
PB Ratio | 3.23 | |||||
Price-to-Tangible-Book | 3.63 | |||||
EV-to-EBIT | 26.3 | |||||
EV-to-EBITDA | 24.64 | |||||
EV-to-Revenue | 2.65 | |||||
EV-to-FCF | -54.07 | |||||
Price-to-Graham-Number | 2.11 | |||||
| Price-to-Net-Current-Asset-Value | 4.99 | |||||
Earnings Yield (Greenblatt) % | 3.8 | |||||
FCF Yield % | -2.09 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mahamaya Lifesciences Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 1,658.093 | ||
| EPS (TTM) (₹) | 3.72 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 46.38 | ||
| 14-Day ATR (₹) | 4.499271 | ||
| 20-Day SMA (₹) | 167.985 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (₹) | 111 - 205.05 | ||
| Shares Outstanding (Mil) | 23.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mahamaya Lifesciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mahamaya Lifesciences Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Mahamaya Lifesciences Ltd Frequently Asked Questions
What is Mahamaya Lifesciences Ltd(BOM:544611)'s stock price today?
The current price of BOM:544611 is ₹166.45. The 52 week high of BOM:544611 is ₹205.05 and 52 week low is ₹111.00.
When is next earnings date of Mahamaya Lifesciences Ltd(BOM:544611)?
The next earnings date of Mahamaya Lifesciences Ltd(BOM:544611) is .
Does Mahamaya Lifesciences Ltd(BOM:544611) pay dividends? If so, how much?
Mahamaya Lifesciences Ltd(BOM:544611) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Mahamaya Lifesciences Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers